Cargando…
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities
China's National Immunization Program has made remarkable achievements but does not include several important childhood vaccines that are readily available in the private market, such as pneumococcal conjugate vaccine (PCV), rotavirus vaccine, Haemophilus influenzae serotype b (Hib) vaccine, an...
Autores principales: | Zhang, Haijun, Lai, Xiaozhen, Patenaude, Bryan N, Jit, Mark, Fang, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695764/ http://dx.doi.org/10.1016/S2468-2667(23)00248-7 |
Ejemplares similares
-
Coverage and Equity of Childhood Vaccines in China
por: Zhang, Haijun, et al.
Publicado: (2022) -
Estimating global and regional between-country inequality in routine childhood vaccine coverage in 195 countries and territories from 2019 to 2021: a longitudinal study
por: Lai, Xiaozhen, et al.
Publicado: (2023) -
Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research
por: Charani, Esmita, et al.
Publicado: (2021) -
How does domestic migration pose a challenge in achieving equitable social health insurance benefits in China? A national cross-sectional study
por: Wang, Haiqin, et al.
Publicado: (2022) -
Misplaced priorities in the Union Health Budget 2015
por: Bhaumik, Soumyadeep
Publicado: (2015)